Activation strategies for invariant natural killer T cells
Immunogenetics · 2016-08 · 68 (8) · 649-663
DOI: 10.1007/s00251-016-0944-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunogenetics, online erschienen am 25.07.2016. Verfasst von Ayano C Kohlgruber und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Invariant natural killer T (iNKT) cells are a specialized T cell subset that plays an important role in host defense, orchestrating both innate and adaptive immune effector responses against a variety of microbes. Specific microbial lipids and mammalian self lipids displayed by the antigen-presenting molecule CD1d can activate iNKT cells through their semi-invariant αβ T cell receptors (TCRs). iNKT cells also constitutively express receptors for inflammatory cytokines typically secreted by antigen-presenting cells (APCs) after recognition of pathogen-associated molecular patterns (PAMPs), and they can be activated through these cytokine receptors either in combination with TCR signals, or in some cases even in the absence of TCR signaling. During infection, experimental evidence suggests that both TCR-driven and cytokine-driven mechanisms contribute to iNKT cell activation. While the relative contributions of these two signaling mechanisms can vary widely depending on the infectious context, both lipid antigens and PAMPs mediate reciprocal activation of iNKT cells and APCs, leading to downstream activation of multiple other immune cell types to promote pathogen clearance. In this review, we discuss the mechanisms involved in iNKT cell activation during infection, focusing on the central contributions of both lipid antigens and PAMP-induced inflammatory cytokines, and highlight in vivo examples of activation during bacterial, viral, and fungal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. pbrennan3@partners.org.
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Kohlgruber, A. C., Donado, C. A., LaMarche, N. M., Brenner, M. B., & Brennan, P. J. (2016). Activation strategies for invariant natural killer T cells. Immunogenetics, 68(8), 649-663. https://doi.org/10.1007/s00251-016-0944-8
Vancouver
Kohlgruber AC, Donado CA, LaMarche NM, Brenner MB, Brennan PJ. Activation strategies for invariant natural killer T cells. Immunogenetics. 2016;68(8):649-663. doi:10.1007/s00251-016-0944-8
BibTeX
@article{Kohlgruber2016,
author = {Kohlgruber, Ayano C and Donado, Carlos A and LaMarche, Nelson M and Brenner, Michael B and Brennan, Patrick J},
title = {Activation strategies for invariant natural killer T cells},
journal = {Immunogenetics},
year = {2016},
volume = {68},
number = {8},
pages = {649--663},
doi = {10.1007/s00251-016-0944-8}
}
EUVIMED